Literature DB >> 6261919

Increasing incidence of adenocarcinoma of the lung.

J Valaitis, S Warren, D Gamble.   

Abstract

Review of the histology of 219 lung cancers initially diagnosed at Lutheran General Hospital, Park Ridge, Illinois, in 1963-1967 and 1974-1976, confirms the increasing incidence of adenocarcinoma. This is due to an increase of adenocarcinoma in men. In women, the incidence of adenocarcinoma was higher than squamous carcinoma in the earliest period (44% adeno, 18% squamous). The percentage of women with lung cancer has also significantly increased from 19% to 31%, which increases the overall incidence of adenocarcinoma of the lung. As the number of women with lung carcinoma has increased, there has been no change in the percentage of adenocarcinoma in women.

Entities:  

Mesh:

Year:  1981        PMID: 6261919     DOI: 10.1002/1097-0142(19810301)47:5<1042::aid-cncr2820470535>3.0.co;2-5

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  23 in total

1.  Alveolar atypical hyperplasia in association with primary pulmonary adenocarcinoma: a clinicopathological study of 10 cases.

Authors:  F A Carey; W A Wallace; R J Fergusson; K M Kerr; D Lamb
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

2.  Is the incidence of primary adenocarcinoma of the lung increasing?

Authors:  C J Caldwell; C L Berry
Journal:  Virchows Arch       Date:  1996-12       Impact factor: 4.064

3.  Carcinoma of the lung in Ontario gold miners: possible aetiological factors.

Authors:  R A Kusiak; J Springer; A C Ritchie; J Muller
Journal:  Br J Ind Med       Date:  1991-12

4.  Differential expression of VASP in normal lung tissue and lung adenocarcinomas.

Authors:  L Dertsiz; G Ozbilim; Y Kayisli; G A Gokhan; A Demircan; U A Kayisli
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

5.  Cyclic combination chemotherapy in advanced adenocarcinoma of the lung: comparison of two FAM schedules.

Authors:  W K Lam; S Y So; M Ip; D Y Yu
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

Review 6.  Combination chemotherapy for advanced adenocarcinoma of the lung. A review.

Authors:  J B Sørensen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

7.  Transforming growth factor beta 1 as a prognostic factor in pulmonary adenocarcinoma.

Authors:  I Takanami; T Imamura; T Hashizume; K Kikuchi; Y Yamamoto; S Kodaira
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

8.  A phosphatidylinositol 3-kinase docking site in the cytoplasmic tail of the Jaagsiekte sheep retrovirus transmembrane protein is essential for envelope-induced transformation of NIH 3T3 cells.

Authors:  M Palmarini; N Maeda; C Murgia; C De-Fraja; A Hofacre; H Fan
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 9.  Lung cancer--current concepts and controversies.

Authors:  S B Pett; J A Wernly; B F Akl
Journal:  West J Med       Date:  1986-07

10.  Mortality from lung cancer in Ontario uranium miners.

Authors:  R A Kusiak; A C Ritchie; J Muller; J Springer
Journal:  Br J Ind Med       Date:  1993-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.